Psicofarma S.A. de C.V.   Report issue

For profit Phase 3
Founded: Mexico City Mexico (1974)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2005
NCT00404326
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Cidat, S.A. de C.V.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Ischemia (Phase 3)

Neoplasms (Phase 2)

Stroke (Phase 3)

Uterine Cervical Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 6